Browsing Artículos (Medicina) by Subject "Breast cancer"
Now showing items 1-9 of 9
-
Article
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
(Nature publishing group, 2021)Identifcation of the diferent elements intervening at the tumor microenvironment seems key to explain clinical evolution ...
-
Article
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
(Amer Publ Co, 2019)Background: Immune escape of tumor cells is a new hallmark of cancer in general, and breast cancer, in particular. ...
-
Article
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
(Mdpi Ag, 2023)Breast cancer (BC) continues to be the most diagnosed tumor in women and a very heterogeneous disease both inter- and ...
-
Article
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
(2020)Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused by the SARS-CoV-2 ...
-
Article
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
(MDPI, 2021-10-29)The PANGEA-Breast trial evaluated a new chemo-immunotherapeutic combination that would synergistically induce long-term ...
-
Article
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer
(Taylor and Francis Group, 2015)Purpose: Improved understanding of risk of recurrence (ROR) is needed to reduce cases of recurrence and more effectively ...
-
Article
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)
(ELSEVIER SCI LTD, 2022)Background The potential benefit of adding palbociclib to fulvestrant as first-line treatment in hormone receptor ...
-
Article
Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells
(Public Library Science, 2016)Obesity is a well-known risk factor for breast cancer development in postmenopausal women. High insulin and leptin levels ...
-
Article
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
(Springer, 2019)Although the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time ...